Becker's Healthcare February 10, 2025
Mariah Taylor

Patients aren’t the only ones turning to obesity drugs to manage health. More physicians are using GLP-1s too, The New York Times reported Feb. 10.

While there are no studies documenting the number of physicians taking GLP-1s, a number of physicians told the Times that they’ve noticed many colleagues growing thinner and sharing similar eating habits.

Physicians “are a good litmus test for drugs that are highly effective,” Robert Califf, MD, the former FDA chief, told the Times.

The increased use of drugs like Wegovy and Zepbound is reminiscent of increased statin use among physicians when those drugs first came out. Back then, cardiologists were among the first to take the drugs in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Physician, Provider
Cyberattack forces physician practice to close indefinitely
AI proves better than humans at analyzing long-term ECG recordings in large international study
How physicians can reignite their spark this year
The physician workforce crisis: What's coming in the next 5 years
Patient engagement tools don't increase 'pajama time' for clinicians, study shows

Share This Article